3941 - 3950 of 7785 Results
Title
Year
- Neuro‐oxysterols and neuro‐sterols as ligands to nuclear receptors, GPCRs, ligand‐gated ion channels and other protein receptors2020RESTRICTEDTitle: Neuro‐oxysterols and neuro‐sterols as ligands to nuclear receptors, GPCRs, ligand‐gated ion channels and other protein receptorsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 178Issue #: 16Start Page: 3176End Page: 3193Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/bph.15191Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.15191Citation Count: 21
- Developing a family engagement plan for Native Hawaiian and Pacific IslanderSTEMstudents in higher education: A review and critique of the literature2020RESTRICTEDTitle: Developing a family engagement plan for Native Hawaiian and Pacific IslanderSTEMstudents in higher education: A review and critique of the literatureJournal Name: Asia Pacific ViewpointPublisher: WileyVol: 62Issue #: 1Start Page: 86End Page: 99Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific, author manuscript, publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1111/apv.12288Best OA location URL: https://rss.onlinelibrary.wiley.com/doi/am-pdf/10.1111/apv.12288Citation Count: 6
- Development and evaluation of [125I]IPPI for Tau imaging in postmortem human Alzheimer's disease brain2020RESTRICTEDTitle: Development and evaluation of [125I]IPPI for Tau imaging in postmortem human Alzheimer's disease brainJournal Name: SynapsePublisher: WileyVol: 75Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/syn.22183Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373522Citation Count: 12
- Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era2020RESTRICTEDTitle: Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine eraJournal Name: Medicinal Research ReviewsPublisher: WileyVol: 40Issue #: 6Start Page: 2650End Page: 2681Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/med.21718Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/med.21718Citation Count: 33
-
RESTRICTEDTitle: Therapeutic innovation in Parkinson’s disease: a 2020 update on disease-modifying approachesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 10Start Page: 1047End Page: 1064Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1800454Citation Count: 12
- Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity2020RESTRICTEDTitle: Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicityJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-020-01004-6Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-020-01004-6Citation Count: 17
- Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain Tissue2020RESTRICTEDTitle: Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain TissueJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 11Issue #: 17Start Page: 2679End Page: 2687Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00336Citation Count: 8
-
RESTRICTEDTitle: Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2174End Page: 2183Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28220Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28220Citation Count: 29
- The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson’s disease2020RESTRICTEDTitle: The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson’s diseaseJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-020-01874-2Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-020-01874-2Citation Count: 10
-
RESTRICTEDTitle: 5Qs: An Activity to Support Students Develop Skills to Interpret Research ObservationsJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.25334/ygq4-5977Citation Count: 0